|
🐜
|
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology
27 auth.
N. Ashton,
W. Brum,
G. Di Molfetta,
A. Benedet,
Burak Arslan,
E. Jonaitis,
Rebecca E Langhough,
K. Cody,
Rachael Wilson,
C. Carlsson,
E. Vanmechelen,
L. Montoliu-Gaya,
J. Lantero-Rodríguez,
N. Rahmouni,
C. Tissot,
...
J. Stevenson,
S. Servaes,
J. Therriault,
T. Pascoal,
A. Lleó,
D. Alcolea,
J. Fortea,
P. Rosa-Neto,
Sterling C. Johnson,
A. Jeromin,
K. Blennow,
H. Zetterberg
|
7 |
2024 |
7
🐜
|
|
🐜
|
Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals
20 auth.
W. Brum,
N. Ashton,
Joel Simrén,
Guiglielmo di Molfetta,
T. Karikari,
A. Benedet,
E. Zimmer,
J. Lantero-Rodríguez,
L. Montoliu-Gaya,
A. Jeromin,
...
A. Aarsand,
William A. Bartlett,
P. F. Calle,
A. Coşkun,
J. Díaz-Garzón,
N. Jonker,
H. Zetterberg,
Sverre Sandberg,
A. Carobene,
K. Blennow
|
4 |
2023 |
4
🐜
|
|
🐜
|
Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology
19 auth.
J. Therriault,
N. Ashton,
I. Pola,
G. Triana-Baltzer,
W. Brum,
G. Di Molfetta,
Burak Arslan,
N. Rahmouni,
C. Tissot,
S. Servaes,
...
J. Stevenson,
A. Macedo,
T. Pascoal,
H. Kolb,
A. Jeromin,
K. Blennow,
H. Zetterberg,
P. Rosa-Neto,
A. Benedet
|
4 |
2024 |
4
🐜
|
|
🐜
|
Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots—A new collection method for remote settings
17 auth.
Hanna Huber,
K. Blennow,
H. Zetterberg,
Mercè Boada,
A. Jeromin,
Haley Weninger,
Raúl Núñez‐Llaves,
N. Aguilera,
Maribel Ramis,
Joel Simrén,
...
J. Nilsson,
J. Lantero-Rodríguez,
A. Orellana,
F. García-Gutiérrez,
Xavier Morató,
N. Ashton,
L. Montoliu-Gaya
|
4 |
2024 |
4
🐜
|
|
🐜
|
Recommendations for clinical implementation of blood‐based biomarkers for Alzheimer's disease
34 auth.
M. M. Mielke,
Matthew Anderson,
J. W. Ashford,
A. Jeromin,
Pei-Jung Lin,
Allyson Rosen,
Jamie Tyrone,
L. Vandevrede,
Deanna R Willis,
O. Hansson,
A. Khachaturian,
S. Schindler,
Joan Weiss,
R. Batrla,
S. Bozeat,
...
John R Dwyer,
Drew Holzapfel,
D. Jones,
James F. Murray,
K. A. Partrick,
Emily Scholler,
G. Vradenburg,
Dylan Young,
J. Braunstein,
Samantha C Burnham,
F. D. de Oliveira,
Y. Hu,
S. Mattke,
Zul Merali,
Mark Monane,
M. Sabbagh,
Eli Shobin,
Michael W Weiner,
Chinedu T Udeh-Momoh
|
3 |
2024 |
3
🐜
|
|
🐜
|
Longitudinal plasma phosphorylated‐tau217 and other related biomarkers in a non‐demented Alzheimer's risk‐enhanced sample
18 auth.
Lianlian Du,
Rebecca E Langhough,
Rachael E Wilson,
Ramiro Eduardo Rea Reyes,
Bruce P. Hermann,
E. Jonaitis,
T. Betthauser,
N. Chin,
Bradley T. Christian,
Lauren E Chaby,
...
A. Jeromin,
Guglielmo Di Molfetta,
W. Brum,
Burak Arslan,
N. Ashton,
K. Blennow,
H. Zetterberg,
S. Johnson
|
3 |
2024 |
3
🐜
|
|
🐜
|
Alzheimer disease biomarker testing in cerebrospinal fluid: a method to harmonize assay platforms in the absence of an absolute reference standard.
8 auth.
H. Vanderstichele,
Leslie M Shaw,
M. Vandijck,
A. Jeromin,
Henrik Zetterberg,
K. Blennow,
...
C. Teunissen,
S. Engelborghs
|
2 |
2013 |
2
🐜
|
|
🐜
|
Considerations for widespread implementation of blood‐based biomarkers of Alzheimer's disease
34 auth.
M. M. Mielke,
Matthew Anderson,
J. W. Ashford,
A. Jeromin,
Pei-Jung Lin,
Allyson Rosen,
Jamie Tyrone,
L. Vandevrede,
Deanna R Willis,
O. Hansson,
A. Khachaturian,
S. Schindler,
Joan Weiss,
R. Batrla,
S. Bozeat,
...
John R Dwyer,
Drew Holzapfel,
D. Jones,
James Murray,
K. A. Partrick,
Emily Scholler,
G. Vradenburg,
Dylan Young,
J. Braunstein,
Samantha C Burnham,
F. D. de Oliveira,
Y. Hu,
S. Mattke,
Zul Merali,
Mark Monane,
M. Sabbagh,
Eli Shobin,
Michael W Weiner,
Chinedu T Udeh-Momoh
|
2 |
2024 |
2
🐜
|
